Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP440385.RAP47uyRDBjaC1pLJRRN2s0FN1Ix5FTTA5m1G0G_QV2do130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP440385.RAP47uyRDBjaC1pLJRRN2s0FN1Ix5FTTA5m1G0G_QV2do130_assertion type Assertion NP440385.RAP47uyRDBjaC1pLJRRN2s0FN1Ix5FTTA5m1G0G_QV2do130_head.
- NP440385.RAP47uyRDBjaC1pLJRRN2s0FN1Ix5FTTA5m1G0G_QV2do130_assertion description "[In this study, resistant sublines of the histiocytic lymphoma cell line U-937 GTB and the myeloma line RPMI 8226 were developed by culturing under gradually increasing concentrations of CHS 828 until reaching 25 times the parental line EC50s.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440385.RAP47uyRDBjaC1pLJRRN2s0FN1Ix5FTTA5m1G0G_QV2do130_provenance.
- NP440385.RAP47uyRDBjaC1pLJRRN2s0FN1Ix5FTTA5m1G0G_QV2do130_assertion evidence source_evidence_literature NP440385.RAP47uyRDBjaC1pLJRRN2s0FN1Ix5FTTA5m1G0G_QV2do130_provenance.
- NP440385.RAP47uyRDBjaC1pLJRRN2s0FN1Ix5FTTA5m1G0G_QV2do130_assertion SIO_000772 15090743 NP440385.RAP47uyRDBjaC1pLJRRN2s0FN1Ix5FTTA5m1G0G_QV2do130_provenance.
- NP440385.RAP47uyRDBjaC1pLJRRN2s0FN1Ix5FTTA5m1G0G_QV2do130_assertion wasDerivedFrom befree-2016 NP440385.RAP47uyRDBjaC1pLJRRN2s0FN1Ix5FTTA5m1G0G_QV2do130_provenance.
- NP440385.RAP47uyRDBjaC1pLJRRN2s0FN1Ix5FTTA5m1G0G_QV2do130_assertion wasGeneratedBy ECO_0000203 NP440385.RAP47uyRDBjaC1pLJRRN2s0FN1Ix5FTTA5m1G0G_QV2do130_provenance.